Literature DB >> 4412696

Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.

H L Davis, D B Rochlin, A J Weiss, W L Wilson, N C Andrews, R Madden, N Sedransk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4412696     DOI： 10.1159/000224901

Source DB:  PubMed          Journal:  Oncology        ISSN： 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  4 in total

1.  The chemotherapy of large-bowel cancer. Present status and future prospects.

Authors:  J Horton; C B Hacker; T J Cunningham; R W Sponzo
Journal:  Am J Dig Dis       Date:  1974-11

2.  An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.

Authors:  Kurt A Jaeckle; Tracy Batchelor; Steven J O'Day; Surasak Phuphanich; Pamela New; Glenn Lesser; Allen Cohn; Mark Gilbert; Robert Aiken; Deborah Heros; Lisa Rogers; Eric Wong; Dorcas Fulton; John C Gutheil; Said Baidas; Julia M Kennedy; Warren Mason; Paul Moots; Christy Russell; Lode J Swinnen; Stephen B Howell
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

3.  Characteristic antitumor activity of cytarabine ocfosfate against human colorectal adenocarcinoma xenografts in nude mice.

Authors:  K Koga; E Iizuka; A Sato; H Ekimoto; M Okada
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Phase I clinical and pharmacokinetic study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.

Authors:  K Kimura; R Ohno; I Amaki; K Hattori; Y Hirota; A Hoshino; M Ichimaru; M Ito; I Kimura; T Maekawa
Journal:  Med Oncol Tumor Pharmacother       Date:  1986
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.